| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.0003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.2 | 0.002 |